B-Cell Enrichment Predictive of Immunotherapy Response in Melanoma, Sarcoma and Kidney Cancer: University of Texas
January 16, 2020
January 16, 2020
HOUSTON, Texas, Jan. 16 [TNSmedicalresearch] -- The University of Texas's MD Anderson Cancer Center issued the following news release on Jan. 15:
* * *
- Multiple studies point to important role for B cells in promoting anti-tumor immunity
* * *
The likelihood of a patient responding to immune checkpoint blockade may depend on B cells in the tumor, located within specialized immune-cell clusters known as tertiary lymphoid structures (TLS), acco . . .
* * *
- Multiple studies point to important role for B cells in promoting anti-tumor immunity
* * *
The likelihood of a patient responding to immune checkpoint blockade may depend on B cells in the tumor, located within specialized immune-cell clusters known as tertiary lymphoid structures (TLS), acco . . .